GFAP and Alzheimer disease: There is increasing evidence from histological studies from mouse models of AD, supporting a link between elevated concentrations of mIns and astrocytic activation (evidenced by an increase in glial fibrillary acidic protein (GFAP) staining), in response to inflammation (Harris et al., 2015).